Provox 2® and Provox Vega® device life-time: a case-crossover study with multivariate analysis of possible influential factors and duration.

Miguel Mayo YanezIrma Cabo-VarelaLoredana Dovalo-CarballoChristian Calvo-HenríquezAlejandro Martínez-MoránJesús Herranz González-Botas

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2018)

Results confirmed the non-significant differences on device life between Provox Vega and Provox 2, as well as the relevant role of radiotherapy treatment in the increase of replacements and diminution of the device duration.

Keyphrases

early stage
squamous cell carcinoma
radiation induced
locally advanced
data analysis
rectal cancer